Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Stryker ( (SYK) ) has provided an announcement. Stryker Corporation has announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share, with a total equity value of approximately $4 ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research note released on Tuesday morning,Zacks.com reports. Several other equities ...

In premarket trading Tuesday, shares were up another 21% to around $78.75, bringing shares closer to the acquisition price Stryker is set to pay. The acquisition of Inari will increase Stryker's ...

Inari is poised to enhance Stryker's footprint ... The company’s portfolio of mechanical thrombectomy devices is set to ‘complement’ Stryker’s neurovascular division.

Perched on a wooded hillside in southern Kyoto, Fushimi Inari is a 1,300-year-old temple dedicated to Inari, the Shinto deity of rice and sake (Japanese rice wine). The shrine complex dates back ...

Following the announcement, Canaccord does not expect other large strategics to push the bid on Inari. TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers.